[A cancer vaccine containing a RAS oncogene-encoded peptide with potential antineoplastic activity. RAS peptide cancer vaccine may stimulate a RAS peptide-specific antitumoral T-cell cytotoxic immune response, resulting in an inhibition of tumor cell proliferation and tumor cell death. (NCI04) ( NCI )]
UMLS (NCI) C0677674 - Pharmacologic Substance
- Immunologic Factor